HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SEM

Select Medical Holdings Corporation (NYSE)

Healthcare — Medical Care Facilities

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania. As of June 30, 2026, Select Medical Holdings Corporation was taken private.

None 3 analysts
$16.50
$-0.05 (-0.30%)
Target: $16.50 (0.0%)
Sign in to add SEM to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$2.05B
P/E Ratio (TTM)15.43
Forward P/E12.04
EPS (TTM)$1.07
Dividend Yield1.51%
Profit Margin2.42%
Revenue Growth5.00%
ROE9.81%
Debt/Equity142.09
Recommendation None
Analyst Target$16.50
Analysts3
Indexes NYSE

Technical Indicators

RSI (14)45.0
Beta0.79
SMA 20-
SMA 40-
52-Week High$16.99
52-Week Low$11.65
50-Day Avg$16.51
200-Day Avg$15.35
Avg Volume$2.28M
Volume$14.27M

Performance Analysis

BEARISH

SEM is flashing more cautionary signals — investors should monitor closely.

- Trading near its 52-week high ($16.99), which may indicate limited upside.
~ RSI at 45.0 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
~ Modest revenue growth of 5.0% year-over-year.
~ Wall Street consensus is "none" from 3 analysts.
- Average analyst target of $16.50 implies 0.0% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:30 UTC

Back to Screener Export Report